Evonik
Tuesday, November 24, 2020
10:00 a.m. EST / 4:00 p.m. CET

Advanced colonic targeting for drug products and other microbiome therapeutics

Back to overview

Overview

Colonic drug delivery is an increasingly desirable option for drugs targeting bowel diseases, treatments with glucocorticoids, microbiome therapeutics, and other oral products that seek to avoid systemic side effects or to reduce the daily dose.

This webinar will review some of the latest pH, time and microbial dependent drug delivery technologies that can enable precise targeting of the colon. Options to enhance the solubility of drug products for colonic applications will also be discussed.

Experts featuring this session

Hans Bär
Head of Global Oral Drug Delivery Services
Evonik Health Care

Vita
Hans is responsible for the global project portfolio of Evonik’s oral drug delivery business. He has extensive experience in the use of functional polymers and oral drug delivery technologies to protect the API, improve targeting and boost drug performance.

One core area of expertise is the use of drug delivery technologies for precise colonic targeting. Hans is the author and co-author of several patent applications and a dozen scientific articles and posters about the application and formulation of pharmaceutical applied polymethacrylates for the preparation of oral solid dosage forms.

He has a degree in pharmaceutical process engineering from the Technical University Bingen, and a Master’s in pharmaceutical medicine from the University of Dusiburg-Essen.

Register now

Details

Webinar language
English

Venue

Online

Questions?

Julia Born
Market Communications Health Care
+49 6151 18 4984 E-Mail
Register now
Evonik Health Care
Company Information
Legal Notice
Privacy Policy